dc.contributor.author |
Detsi, A |
en |
dc.contributor.author |
Bouloumbasi, D |
en |
dc.contributor.author |
Prousis, KC |
en |
dc.contributor.author |
Koufaki, M |
en |
dc.contributor.author |
Athanasellis, G |
en |
dc.contributor.author |
Melagraki, G |
en |
dc.contributor.author |
Afantitis, A |
en |
dc.contributor.author |
Igglessi-Markopoulou, O |
en |
dc.contributor.author |
Kontogiorgis, C |
en |
dc.contributor.author |
Hadjipavlou-Litina, DJ |
en |
dc.date.accessioned |
2014-03-01T01:26:04Z |
|
dc.date.available |
2014-03-01T01:26:04Z |
|
dc.date.issued |
2007 |
en |
dc.identifier.issn |
00222623 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/17919 |
|
dc.subject |
Anti-inflammatory Agent |
en |
dc.subject |
lipoic acid |
en |
dc.subject.other |
antiinflammatory agent |
en |
dc.subject.other |
antioxidant |
en |
dc.subject.other |
n (1,2 dihydro 4 hydroxy 1 methyl 2 oxo 3 quinolinecarbonyl) n' (1,2 dithiolane 3 pentanoyl)ethylenediamine |
en |
dc.subject.other |
n (1,2 dihydro 4 hydroxy 1 methyl 2 oxo 3 quinolinecarbonyl) n' (1,2 dithiolane 3 pentanoyl)hexamethylenediamine |
en |
dc.subject.other |
n (1,2 dihydro 4 hydroxy 2 oxo 1 phenyl 3 quinolinecarbonyl) n' (1,2 dithiolane 3 pentanoyl) 1,2 phenylenediamine |
en |
dc.subject.other |
n (1,2 dihydro 4 hydroxy 2 oxo 1 phenyl 3 quinolinecarbonyl) n' (1,2 dithiolane 3 pentanoyl)ethylenediamine |
en |
dc.subject.other |
n (1,2 dihydro 4 hydroxy 2 oxo 1 phenyl 3 quinolinecarbonyl) n' (1,2 dithiolane 3 pentanoyl)hexamethylenediamine |
en |
dc.subject.other |
n 2 phenylamino 1,2 dihydro 4 hydroxy 1 methyl 2 oxo 3 quinolinecarboxamide |
en |
dc.subject.other |
n 4 phenylamino 1,2 dihydro 4 hydroxy 1 methyl 2 oxo 3 quinolinecarboxamide |
en |
dc.subject.other |
n 4 phenylamino 1,2 dihydro 4 hydroxy 1 phenyl 2 oxo 3 quinolinecarboxamide |
en |
dc.subject.other |
n ethylamino 1,2 dihydro 4 hydroxy 2 oxo 1 phenyl 3 quinolinecarboxamide |
en |
dc.subject.other |
n hexylamino 1,2 dihydro 4 hydroxy 1 methyl 2 oxo 3 quinolinecarboxamide |
en |
dc.subject.other |
nordihydroguaiaretic acid |
en |
dc.subject.other |
quinoline derivative |
en |
dc.subject.other |
trolox C |
en |
dc.subject.other |
unclassified drug |
en |
dc.subject.other |
animal experiment |
en |
dc.subject.other |
animal model |
en |
dc.subject.other |
antiinflammatory activity |
en |
dc.subject.other |
antioxidant activity |
en |
dc.subject.other |
article |
en |
dc.subject.other |
drug structure |
en |
dc.subject.other |
drug synthesis |
en |
dc.subject.other |
female |
en |
dc.subject.other |
male |
en |
dc.subject.other |
nonhuman |
en |
dc.subject.other |
rat |
en |
dc.subject.other |
structure activity relation |
en |
dc.subject.other |
Amides |
en |
dc.subject.other |
Animals |
en |
dc.subject.other |
Anti-Inflammatory Agents, Non-Steroidal |
en |
dc.subject.other |
Antioxidants |
en |
dc.subject.other |
Biphenyl Compounds |
en |
dc.subject.other |
Carrageenan |
en |
dc.subject.other |
Dimethyl Sulfoxide |
en |
dc.subject.other |
Edema |
en |
dc.subject.other |
Female |
en |
dc.subject.other |
Hydrazines |
en |
dc.subject.other |
Hydroxyl Radical |
en |
dc.subject.other |
Lipoxygenase Inhibitors |
en |
dc.subject.other |
Male |
en |
dc.subject.other |
Oxidation-Reduction |
en |
dc.subject.other |
Quinolones |
en |
dc.subject.other |
Rats |
en |
dc.subject.other |
Rats, Inbred F344 |
en |
dc.subject.other |
Structure-Activity Relationship |
en |
dc.subject.other |
Thioctic Acid |
en |
dc.title |
Design and synthesis of novel quinolinone-3-aminoamides and their α-lipoic acid adducts as antioxidant and anti-inflammatory agents |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1021/jm061173n |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1021/jm061173n |
en |
heal.publicationDate |
2007 |
en |
heal.abstract |
A series of N-substituted-quinolinone-3-aminoamides and their hybrids containing the α-lipoic acid functionality were designed and synthesized as potential bifunctional agents combining antioxidant and anti-inflammatory activity. The new compounds were evaluated for their antioxidant activity and for their ability to inhibit in vitro lipoxygenase as well as for their anti-inflammatory activity in vivo. In general, the derivatives were found to be potent antioxidant or anti-inflammatory agents. The results are discussed in terms of structure-activity relationships and an attempt is made to define the structural features required for activity. © 2007 American Chemical Society. |
en |
heal.journalName |
Journal of Medicinal Chemistry |
en |
dc.identifier.doi |
10.1021/jm061173n |
en |
dc.identifier.volume |
50 |
en |
dc.identifier.issue |
10 |
en |
dc.identifier.spage |
2450 |
en |
dc.identifier.epage |
2458 |
en |